Paul Dossa
Investor at Venrock · New York City, United States
Invests in AIPaul Dossa's investor profile lists AI alongside Biotech & Pharma and Robotics & Automation, at early-stage venture. The record holds 68 deals, among them Nightfall AI, Biolux Research and Dapper Labs.
Email InvestorCredits to line up before an early-stage round
Paul Dossa backs companies at early-stage venture. A few of the larger credit programs on AI Perks for teams at that point:
Portfolio on record
Portfolio companies
- Nightfall AI
- Biolux Research
- Dapper Labs
- Constellation Pharmaceuticals
- Olema Oncology
- Dynamic Signal
- Encoded Therapeutics
- Interos
- Suki
- Luma
- Simbe Robotics
- Iris Medicine
- Concentric Analgesics
- Skyryse
- Mable
- Orchard Therapeutics
- Quiq
- Aledade
- Doctor On Demand
- Hua Medicine
- 3Box
- Cyteir Therapeutics
- Aria Systems
- Chisel.ai
- Tricida
- Numerated
- Astranis
- Waybridge
- UNITY Biotechnology
- Federation Bio
- Misty Robotics
- Inscripta
- Salsify
- Running Tide
- Renew Health
- CrowdJustice
- Workframe
- Kyruus
- Altruist
- Auditoria.AI
- Devoted Health
- Corvidia
- Ombud
- Atom Computing
- Amunix
- Lyra Health
- Keros Therapeutics
- Socrates.AI, Inc.
- Astronomer
- Rebellion Defense
Showing 50 of 68 deals on record.
Investment focus
- Backs startups in
- Artificial Intelligence, Biotech & Pharma, Robotics & Automation
- Rounds
- Early-stage venture
- Profile
- Venture investor
- Deals on record
- 68
- Based in
- New York City, United States

Ready to pitch AI investors?
AI Perks profiles show public professional information only, so there are no contact details here. Continue to find investors, send your pitch and track the replies.
Email InvestorMore AI investors on AI Perks
- Bill CoughranFounder's Coach and Partner at Sequoia Capital
- Rajeev DhamManaging Director at Sapphire Ventures
- Kanu GulatiPartner at Khosla Ventures
- Anis UzzamanVenture investor in San Jose
- Konstantine BuhlerPartner @ Series D and Beyond at Waymo
- Randy WilliamsAngel investor in San Francisco
- Alice BrooksPartner at Khosla Ventures
- Vinod KhoslaPartner at Khosla Ventures
Questions founders ask
- Does Paul Dossa invest in AI startups?
- Yes. Artificial Intelligence is one of the sectors on Paul Dossa's investor profile, together with Biotech & Pharma and Robotics & Automation. The stages on record are early-stage venture.
- Which companies has Paul Dossa backed?
- The record lists 68 deals, including Nightfall AI, Biolux Research, Dapper Labs, Constellation Pharmaceuticals and Olema Oncology. None of them has a perk listed on AI Perks yet.
- What credits can a startup claim before pitching Paul Dossa?
- For a company raising an early-stage round, AI Perks lists credits such as Confluent (up to $20,000), AI21 Labs (up to $10,000), Confluent (up to $20,000) and NVIDIA (up to Varies), with each program's terms and how to apply.
- Does AI Perks publish investor contact details?
- No. AI Perks profiles show public professional information only: name, role, location, stages, sectors and the portfolio on record. To reach investors, continue with the Email Investor button below.Email Investor
Source: public professional information. Is this you? Request removal